Risk factors of recurarization after insufficient sugammadex administration: Effects of obesity and obstructive sleep apnea

Risk factors of recurarization after insufficient sugammadex administration: Effects of obesity and obstructive sleep apnea - Effects of obesity and obstructive sleep apnea on recurarization following insufficient sugammadex

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030263

Enrollment

Registered

2017-12-05

Start date

2017-12-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with obesity, patients with obstructive sleep apnea, patients undergoing elective surgery

Interventions

infusion of insufficient sugammadex

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: elective surgical patients under general anesthesia: 20 non-obese patients (BMI less than 25kg/m2) and 20 obese patients (BMI greater than 30 kg/m2)

Exclusion criteria

Exclusion criteria: Exclusion criteria were 1) patients with severe comorbidities, 2) allergies for muscle relaxants, propofol and sugammadex, 3) patients undergoing surgeries undesirable for administration of rocuronium and sugammadex, and 4) patients taking drugs that influence rocuronium and sugammadex such as antiepileptic agents, estrogen preparation, rifampicin and verapamil, 5) patients who the researcher judged inappropriate as the subject

Design outcomes

Primary

Measure	Time frame
TOF ratio recovery speed	—

Secondary

Measure	Time frame
Variables obtained from the neuromuscular monitoring, background variables	—

Countries

Japan

Contacts

Public ContactTakahiro Muramatsu

Chiba University Department of Anesthesiology, Graduate School of Medicine

rudy_sippo@yahoo.co.jp+81-43-226-2155

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026